#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness neurosensory Chronic granulomatous disease Factor VIII deficiency Toxic epidermal necrolysis Neurofibromatosis Infantile spasms Neuropathic arthropathy Bone marrow disorder Arteriovenous malformation Non-Hodgkin's lymphoma Anal cancer Primary hyperoxaluria Malformation venous Dent's disease Haemophilia B without inhibitors More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic Breast angiosarcoma – Life with Disease Factor IX deficiency – Diagnostics Pemphigoid – Trials in Disease Friedreich’s ataxia – Life with Disease Mitochondrial myopathy – Treatment Choroid melanoma Phenylketonuria Myxofibrosarcoma – Diagnostics Systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Edg-5506 Dabrafenib Insulin Aspart Ondansetron Montelukast Sodium Lutropin Alfa Mavorixafor Cdr132L Sodium Cendakimab Mometasone Sulodexide ICOTROKINRA Selgantolimod Cortisone 11902A Rapcabtagene Autoleucel Aup1602-C Erenumab AZD0022 TX000045 More therapies…

    Learn about Your Condition

    Cerebral haemorrhage Micrographic skin surgery Pancreaticoduodenectomy Conjunctivitis allergic Bile acid synthesis disorder Cutaneous sarcoidosis Head and neck cancer Arrhythmia supraventricular Spinal pain Skin disorder Alagille syndrome Cystic fibrosis Essential hypertension Arterial disorder Fracture infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

MELAS syndrome

  • A study testing sonlicromanol in adults with genetically confirmed mitochondrial DNA 3243A>G variant causing mitochondrial disease

    Recruiting

    3 1
    Investigated Diseases:
    • MELAS syndrome
    • Mitochondrial myopathy
    Denmark France Germany Italy The Netherlands

  • Study on the Safety and Effectiveness of Zagociguat for Treating MELAS in Patients

    Not recruiting

    2 1
    Investigated Drugs:
    • Zagociguat
    Germany Italy

  • Long-term safety study of zagociguat tablets in patients with MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who completed previous trial

    Not recruiting

    2 1 1
    Investigated Diseases:
    • MELAS syndrome
    Investigated Drugs:
    • Zagociguat
    Germany Italy

  • Study on the Effects of TTI-0102 for Patients with MELAS Syndrome

    Not recruiting

    2 1
    Investigated Drugs:
    • Mercaptamine-Pantetheine Disulfide Acetate
    France The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!